{"slideshow_credits": null, "snippet": "The British drug maker plans to acquire treatments at various stages of research in a deal with Bristol-Myers Squibb of New York that could be worth $1.46 billion.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/12/19/business/dealbook/gsk-bristol-myers-hiv.html", "lead_paragraph": "The British drug maker plans to acquire treatments at various stages of research in a deal with Bristol-Myers Squibb of New York that could be worth $1.46 billion.", "headline": {"main": "GlaxoSmithKline to Buy Raft of H.I.V. Drugs in Development"}, "_id": "5673f32038f0d85bed90f5e1", "word_count": "206", "multimedia": [], "pub_date": "2015-12-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Acquired Immune Deficiency Syndrome", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Bristol Myers Squibb Company", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "6"}, {"name": "glocations", "value": "London (England)", "is_major": "N", "rank": "7"}, {"name": "glocations", "value": "Japan", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}